[DOI] [PubMed] [Google Scholar] 46.Fruehauf JP, Trapp V
Current dose is 0.5 mg weekly after 4 weeks at 0.25 mg
Users commonly describe this route as appealing when they want the benefits to feel more whole-body less about putting something on one spot and more about supporting the repair environment everywhere
Their regenerative profiles make them popular candidates for tendon, ligament, and muscle injury research
However, some optimistic signs are dawning, with some recent works employing cutting-edge technologies such as patient-derived organoid culture and single-cell RNA sequencing, which have connected ASD development with the haploinsufficiency of epigenetic factors and chromatin remodelers (SUV420H1/KMT5B, ARID1B, and CHD8) [196], while the inhibition of LSD1 demethylase has been observed to reverse ASD phenotypes in mice [197]
TRIUMPH-4 was the first to report positive results in December 2025